309 related articles for article (PubMed ID: 15351192)
1. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial.
Poole-Wilson PA; Lubsen J; Kirwan BA; van Dalen FJ; Wagener G; Danchin N; Just H; Fox KA; Pocock SJ; Clayton TC; Motro M; Parker JD; Bourassa MG; Dart AM; Hildebrandt P; Hjalmarson A; Kragten JA; Molhoek GP; Otterstad JE; Seabra-Gomes R; Soler-Soler J; Weber S;
Lancet; 2004 Sep 4-10; 364(9437):849-57. PubMed ID: 15351192
[TBL] [Abstract][Full Text] [Related]
2. Action: a 30,000 patient-years double-blind, placebo-controlled trial of nifedipine GITS in stable angina. ACTION Research Group.
Lubsen J; Poole-Wilson PA
Br J Clin Pract Suppl; 1997 Apr; 88():23-6. PubMed ID: 9519504
[TBL] [Abstract][Full Text] [Related]
3. Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic System.
Lubsen J; Poole-Wilson PA; Pocock SJ; van Dalen FJ; Baumann J; Kirwan BA; Parker AB
Eur Heart J; 1998 Aug; 19 Suppl I():I20-32. PubMed ID: 9743440
[TBL] [Abstract][Full Text] [Related]
4. [ACTION: The clinical study of the month].
Piérard LA
Rev Med Liege; 2005 Jan; 60(1):61-3. PubMed ID: 15771319
[TBL] [Abstract][Full Text] [Related]
5. Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome.
Ruilope LM; Kirwan BA; de Brouwer S; Danchin N; Fox KA; Wagener G; Segura J; Poole-Wilson PA; Lubsen J;
J Hypertens; 2007 Aug; 25(8):1711-8. PubMed ID: 17620970
[TBL] [Abstract][Full Text] [Related]
6. Resource utilization implications of treatment were able to be assessed from appropriately reported clinical trial data.
Poole-Wilson PA; Kirwan BA; Vokó Z; de Brouwer S; Dunselman PH; van Dalen FJ; Lubsen J;
J Clin Epidemiol; 2007 Jul; 60(7):727-33. PubMed ID: 17573989
[TBL] [Abstract][Full Text] [Related]
7. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial.
Lubsen J; Wagener G; Kirwan BA; de Brouwer S; Poole-Wilson PA;
J Hypertens; 2005 Mar; 23(3):641-8. PubMed ID: 15716708
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
Brown MJ; Palmer CR; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
Lancet; 2000 Jul; 356(9227):366-72. PubMed ID: 10972368
[TBL] [Abstract][Full Text] [Related]
9. Nifedipine GITS versus diltiazem in chronic stable angina: a randomised multicentre study.
Zanolla L; Franceschini L; Rossi L; Ochan M; Amigoni S; Zardini P
Br J Clin Pract Suppl; 1997 Apr; 88():27-35. PubMed ID: 9519505
[TBL] [Abstract][Full Text] [Related]
10. The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension.
Sierra C; Coca A
Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1055-62. PubMed ID: 18793108
[TBL] [Abstract][Full Text] [Related]
11. Monotherapy with nifedipine GITS compared with atenolol in stable angina pectoris. The Working Group on Cardiovascular Research (WCN).
de Vries RJ; Dunselman PH
Br J Clin Pract Suppl; 1997 Apr; 88():6-9. PubMed ID: 9519501
[TBL] [Abstract][Full Text] [Related]
12. Safety of nifedipine GITS in stable angina: the ACTION trial.
Poole-Wilson PA; Kirwan BA; Vokó Z; de Brouwer S; van Dalen FJ; Lubsen J;
Cardiovasc Drugs Ther; 2006 Feb; 20(1):45-54. PubMed ID: 16552473
[TBL] [Abstract][Full Text] [Related]
13. Nifedipine in unstable angina: a double-blind, randomized trial.
Gerstenblith G; Ouyang P; Achuff SC; Bulkley BH; Becker LC; Mellits ED; Baughman KL; Weiss JL; Flaherty JT; Kallman CH; Llewellyn M; Weisfeldt ML
N Engl J Med; 1982 Apr; 306(15):885-9. PubMed ID: 7038491
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure reduction in stable angina by nifedipine was related to stroke and heart failure reduction but not to coronary interventions.
Lubsen J; Vokó Z; Poole-Wilson PA; Kirwan BA; de Brouwer S;
J Clin Epidemiol; 2007 Jul; 60(7):720-6. PubMed ID: 17573988
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
16. Tracking coronary calcification and atherosclerotic lesions in patients with stable angina pectoris undergoing nifedipine therapy.
Motro M; Kirwan BA; de Brouwer S; Poole-Wilson PA; Shemesh J;
Cardiology; 2007; 107(3):165-71. PubMed ID: 16940720
[TBL] [Abstract][Full Text] [Related]
17. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and tolerability of felodipine and nifedipine in stable angina refractory to beta-blocker therapy].
Mazzotta G; Falcidieno M; Ravera E; Vecchio C
G Ital Cardiol; 1996 Apr; 26(4):407-17. PubMed ID: 8707025
[TBL] [Abstract][Full Text] [Related]
19. [ACTION study: efficacy of nifedipine in preventing cardiovascular disease in patients with coronary artery disease].
Shimokawa H
Drugs; 2006; 66 Spec No 1():10-2. PubMed ID: 18200771
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
Schnellbacher K; Bestehorn HP; Roskamm H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
